Y.-H. Ou
Impact in
- Rheumatology top 10%
- Bone and Dental Protein Studies
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Cancer, Lipids, and Metabolism 2
- Carcinogens and Genotoxicity Assessment 1
- Co-authors
- Hung‐Wei PanPo‐Lin LaiHey‐Chi HsuShian‐Yang PengChi‐Ling ChenJin‐Chuan SheuPo‐Huang LeeShengkun Peng
In The Last Decade
Y.-H. Ou
7 papers receiving 337 citations
Peers
Comparison fields: 5 of 49
- Rheumatology 125
- Hepatology 45
- Cancer Research 85
- Biotechnology 46
- Oncology 106
Countries citing papers authored by Y.-H. Ou
This map shows the geographic impact of Y.-H. Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y.-H. Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y.-H. Ou more than expected).
Fields of papers citing papers by Y.-H. Ou
This network shows the impact of papers produced by Y.-H. Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y.-H. Ou. The network helps show where Y.-H. Ou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Y.-H. Ou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2007 | 53 | |
| 4 | Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma. | 2005 | 17 |
| 5 | 2005 | 27 | |
| 6 | 2004 | 25 | |
| 7 | 2003 | 216 | |
| 8 | 1992 | 6 |
About Y.-H. Ou
Y.-H. Ou is a scholar working on Cancer Research, Endocrine and Autonomic Systems, Oral Surgery, Biotechnology and Pharmacology, having authored 8 papers that have together received 345 indexed citations. Recurring topics across this work include RNA modifications and cancer (2 papers), Peptidase Inhibition and Analysis (2 papers), Cancer, Lipids, and Metabolism (2 papers), S100 Proteins and Annexins (2 papers), Glycosylation and Glycoproteins Research (1 paper), Cancer Research and Treatments (1 paper), Renal cell carcinoma treatment (1 paper) and Carcinogens and Genotoxicity Assessment (1 paper). The work is most often cited by research in Rheumatology (125 citations), Hepatology (45 citations), Cancer Research (85 citations), Biotechnology (46 citations) and Oncology (106 citations). Y.-H. Ou has collaborated with scholars based in Taiwan, Australia and Singapore. Frequent co-authors include Hung‐Wei Pan, Po‐Lin Lai, Hey‐Chi Hsu, Shian‐Yang Peng, Chi‐Ling Chen, Jin‐Chuan Sheu, Po‐Huang Lee, Shengkun Peng, H C Hsu and Wen‐Ling Kuo. Their work appears in journals such as Cancer, Helicobacter, European Journal of Cancer, Journal of Dental Research and Journal of Toxicology and Environmental Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.